Carson Seana 4
4 · Bausch Health Companies Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Carson Seana
EVP, General Counsel
Transactions
- Award
Common Shares, No Par Value
2024-02-29+147,536→ 530,461 total - Tax Payment
Common Shares, No Par Value
2024-03-01$9.89/sh−765$7,566→ 529,696 total - Tax Payment
Common Shares, No Par Value
2024-03-01$9.89/sh−5,994$59,281→ 523,702 total - Tax Payment
Common Shares, No Par Value
2024-03-01$9.89/sh−16,973$167,863→ 506,729 total - Tax Payment
Common Shares, No Par Value
2024-03-01$9.89/sh−511$5,054→ 506,218 total - Sale
Common Shares, No Par Value
2024-03-04$9.80/sh−4,420$43,316→ 501,798 total - Sale
Common Shares, No Par Value
2024-03-04$9.80/sh−199$1,950→ 501,599 total - Sale
Common Shares, No Par Value
2024-03-04$9.80/sh−1,561$15,298→ 500,038 total - Sale
Common Shares, No Par Value
2024-03-04$9.80/sh−133$1,303→ 499,905 total
Footnotes (3)
- [F1]Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
- [F2]This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
- [F3]Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2023.